Coagulation Dynamics in Factor V Deficiency: A Family Study, with a Note on the Occurrence of Thrombophlebitis^[1], ^[2], ^[3]

Summary

1. A family with congenital proaccelerin (factor V) deficiency is here reported. The mode of inheritance appears to be by means of an autosomal recessive gene. The homozygous propositus (proaccelerin less than 2% of normal) had a life-long, moderately severe, bleeding tendency. The heterozygotes (proaccelerin 45 to 66%) were clinically normal.

2. Studies on the rate of consumption of coagulation factors during blood clotting revealed normal consumption of antihemophilic globulin (factor VIII), but defective consumption of prothrombin (II) in the propositus. This indicated the entry of proaccelerin into the clotting process between the stages at which antihemophilic globulin and prothrombin are involved. Five of the seven heterozygotes studied showed a similar pattern. These findings are consistent with current theories of the role of proaccelerin in the normal sequence of events in the coagulation scheme.

3. The propositus had an episode of thrombosis of the deep saphenous vein which is apparently a unique occurence in the literature of proaccelerin deficiency.

• References

• 1 Owren P. A. Parahaemophilia: Hemorrhagic diathesis due to absence of a previously unknown clotting factor. Lancet I: 446 1947;
• 2 Rodman Jr. N. F, Barrow E. M, Graham J. B. Diagnosis and control of hemophiloid states with the partial thromboplastin time (PTT) test. Amer. J. clin. Path. 29: 525 1958;
• 3 Proctor R. R, Rapaport S. I. The partial thromboplastin time with Kaolin. Amer. J. clin. Path. 50: 212-219 1961;
• 4 Miller S. P. Congenital deficiency of proconvertin: A clinical and laboratory report. Blood 14: 1322-1338 1959;
• 5 Miller S. P, Siggerud J. Abnormal coagulation in carriers of hemophilia. J. Lab. clin. Med. 63: 621 1964;
• 6 Stormorken H. The preparation of proaccelerin deficient (parahemophilia) plasma for the assay of proaccelerin. Scand. J. clin. Lab. Invest. 9: 273 1957;
• 7 Borchgrevink G. F, Pool J. G, Stormorken H. A new assay for Factor V (proaccelerin-acce-lerin) using Russell’s Viper Venon. J. Lab. clin. Med. 55: 625 1960;
• 8 Pool J. G, Robinson J. Assay of plasma anti-haemophilic globulin (AHG). Brit. J. Haem. 5: 17 1959;
• 9 Hjort P, Rapaport S. I, Owren P. A. A simple, specific one-stage prothrombin assay, using Russell’s Viper Venom in cephalin suspension. J. Lab. clin. Med. 46: 89 1955;
• 10 Hougie C. Studies on the fate of coagulation factors during the clotting of normal and pathological blood. Thrombos. Diathes. haemorrh. (Stuttg.) 3: 578-587 1959;
• 11 Fantl P. Parahemophilia (proaccelerin deficiency) occurrence and biochemistry. In: Hemophilia and Hemophiloid Diseases. edited by Brinkhous K. M. Chapel Hill: University of North Carolina Press; 1957
• 12 Biggs R, Gaston L. W. The blood clotting factors. In: Metabolic Basis of Inherited Disease. edited by Stanbury J. B. N. Y.: McGraw-Hill Book Co.; 1960
• 13 Biggs R, MacFarlane R. G. Human Blood Coagulation and its Disorders. 203 F. A. Davis Co.; Philadelphia: 1962
• 14 Field J. B, Ware A. G. Studies on parahemophilia. J. clin. Invest. 33: 932 1954;
• 15 Kingsley C. S. Familial Factor V deficiency; the pattern of heredity. Quart. J. med. n. s. 23: 323 1954;
• 16 Lewis J. H, Ferguson J. H. Hypoproaccelerinemia. Blood 10: 351 1955;
• 17 Sacks M. S, Baccaglia G. Heredity deficiency of proaccelerin (parahemophilia): A family study. J. Lab. clin. Med. 46: 98 1955;
• 18 Owen Jr. G. A, Cooper T. Parahemophilia. A. M. A. Arch. int. Med. 95: 194 1955;
• 19 Friedman I. A, Quick A. J, Higgins F, Hussey C. V, Hickey M. E. Heredity labile factor (Factor V) deficiency. J. A. M. A. 175: 370 1961;
• 20 Philips L. L, Little W. A. Factor V deficiency in obstetrics. Obst. Gynec. 19: 507 1962;
• 21 Owren P. A, Rapaport S. I, Hjort P, Aas J. The biochemistry of thromboplastin, its formation and action. Sang. 25: 752-765 1954;
• 22 Bergsagel D. E, Hougie C. Intermediate stages in the formation of blood thromboplastin. Brit. J. Haem. 2: 113 1956;
• 23 Hougie C. The role of Factor V in the formation of blood thromboplastin. J. Lab. clin. Med. 50: 16 1957;
• 24 Stohlman F, Harrington W. J, Moloney W. C. Parahemophilia (Owren⁵s Disease), Report of a case of a women with studies of other members of her family. J. Lab. clin. Med. 38: 842 1951;
• 25 Douglas A. S. Antihemophilic globulin consumption during blood coagulation. Blood 11: 423 1956;
• 26 Soulier J. P, Gobbi F, Larrieu M. J. Séparation du fibrinogène et du facteur antihemophili-que A. Rev. Hémat. 12: 481 1957;
• 27 Miller S. P. Personal Observations
• 28 Rodman G. P, Brower T. D, Hellstrom H. R, Didisheim P, Lewis J. H. Post-mortem examination of an elderly severe hemophiliac, with observations on the pathologic findings in hemophilic joint disease. Arth. Rheum. 2: 152-161 1959;
• 29 Stewart J, Acheson E. D. Atherosclerosis in a hemophiliac. Lancet I: 1121 1957;
• 30 Boivin J. M. Infarctus du myocarde chez un hémophile. Arch. Mal. Coeur 47: 351 1954;
• 31 Godai H. C, Madsen K, Nissen-Meyer R. Thrombo-Embolism in patients with total proconvertin (Factor VII) deficiency. Acta medica scand. 171: 325 1962;
• 32 Quick A. J. On the probable mechanism of intravascular clotting. Angiology 7: 419-425 1956;